DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Loews Sapphire Falls Resort

2019年3月18日 (月) 午前 11:00 - 2019年3月20日 (水) 午後 1:30

6601 Adventure Way,, Orlando, FL 32819

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 9 Track 2: Automation Technologies in Medical Writing

Session Chair(s)

Ruggero  Galici, PhD

Ruggero Galici, PhD

Director, Nonclinical and Clinical Pharmacology Writing

Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States

Automation technologies, especially when combined with artificial intelligence, are disrupting many sectors including the healthcare. This session will explore challenges and opportunities of automation technologies in medical writing. Few examples of how companies and the FDA are using or plan to use automation technologies to improve efficiencies will be discussed.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify potential automation technologies in medical writing
  • Recognize challenges and opportunities when implementing automation technologies in medical writing

Speaker(s)

Sian  Ratcliffe, PhD

Automation and AI in Medical Writing: Pie in the Sky or a Paradigm Shift?

Sian Ratcliffe, PhD

Pfizer Inc, United States

Vice President, Head of Medical Writing

Julia  Forjanic-Klapproth, PhD

AI in the Medical Writing Landscape – Tales from a Pilot Project

Julia Forjanic-Klapproth, PhD

Trilogy Writing & Consulting, Germany

Senior Partner

Eileen E. Navarro Almario, MD, MS, FACP

Digitizing Decision Documentation at the FDA – Are We There Yet?

Eileen E. Navarro Almario, MD, MS, FACP

FDA, United States

Lead Physician

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。